AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35688793 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid responders
Number of subjects: 373
Study 35688793 — intervention group
Group type: EXPERIMENTAL
Intervention: Late responders
Number of subjects: 373
Study 32750916 — intervention group
Group type: EXPERIMENTAL
Intervention: Camera-based HR monitoring technique using iPPG signals extracted from video recordings.
Number of subjects: 9
Study 32396206 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week nurse-led intervention for adolescents with PIU
Number of subjects: 100
Study 32396206 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (received intervention after posttest)
Number of subjects: 100
Study 35138027 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic application of iBond Self‐Etch adhesive
Number of subjects: 40
Study 35138027 — intervention group
Group type: COMPARATOR
Intervention: Manual application of iBond Self‐Etch adhesive
Number of subjects: 40
Study 33398936 — intervention group
Group type: EXPERIMENTAL
Intervention: PEERS® intervention
Number of subjects: 0
Study 33398936 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 0
Study 34161776 — intervention group
Group type: EXPERIMENTAL
Intervention: REGEN-COV (two-antibody combination)
Number of subjects: 0
Study 34161776 — intervention group
Group type: COMPARATOR
Intervention: Single monoclonal antibody treatments
Number of subjects: 0
Study 34161776 — intervention group
Group type: COMPARATOR
Intervention: Dual or triple antibody combinations (in vitro studies)
Number of subjects: 0
Study 32155576 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive education group (IEG)
Number of subjects: 92
Study 32155576 — intervention group
Group type: COMPARATOR
Intervention: Regular education group (REG)
Number of subjects: 92
Study 33417507 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held (HH) Nomad Pro 2 X-ray device
Number of subjects: 205
Study 33417507 — intervention group
Group type: COMPARATOR
Intervention: Wall-mounted (WM) KaVo Focus X-ray device
Number of subjects: 205
Study 33417507 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HH and WM devices
Number of subjects: 205
Study 32476539 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 6540
Study 32476539 — intervention group
Group type: COMPARATOR
Intervention: No ICD
Number of subjects: 6540
Study 36223599 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal hydrolaparoscopy (THL)
Number of subjects: 300
Study 36223599 — intervention group
Group type: COMPARATOR
Intervention: Hysterosalpingography (HSG)
Number of subjects: 300
Study 34034702 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation of seven CpGs (cg10399824, cg05275153, cg24406668, cg14719951, cg25117092, cg11348188, cg11671115)
Number of subjects: 381
Study 34034702 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation of five CpGs (cg10399824, cg24406668, cg14719951, cg25117092)
Number of subjects: 381
Study 34034702 — intervention group
Group type: EXPERIMENTAL
Intervention: Three methylation correlated blocks (MCBs) involving cg11671115, cg14719951, and cg24406668
Number of subjects: 381
Study 34034702 — intervention group
Group type: EXPERIMENTAL
Intervention: Two risk score models based on key CpG loci
Number of subjects: 381
Study 35149907 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemna minor
Number of subjects: 24
Study 35149907 — intervention group
Group type: COMPARATOR
Intervention: Spinach
Number of subjects: 24
Study 35149907 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemna minor and Spinach
Number of subjects: 24
Study 34340242 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-based reminders delivered one day after notification of vaccine eligibility
Number of subjects: 160446
Study 34340242 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-based reminders delivered eight days after notification of vaccine eligibility
Number of subjects: 160446
Study 34340242 — intervention group
Group type: EXPERIMENTAL
Intervention: First reminder designed to induce feelings of ownership over the vaccine dose
Number of subjects: 160446
Study 34340242 — intervention group
Group type: COMPARATOR
Intervention: Combination of first reminder with a video-based information intervention
Number of subjects: 160446
Study 32660848 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported voice problems
Number of subjects: 426
Study 32660848 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice problems
Number of subjects: 426
Study 33894465 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopedic insoles (OIs)
Number of subjects: 32
Study 33894465 — intervention group
Group type: COMPARATOR
Intervention: Sham insole (SI)
Number of subjects: 32
Study 35757330 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenqisuxin granule (SQSX) plus conventional treatment
Number of subjects: 66
Study 35757330 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus conventional treatment
Number of subjects: 66
Study 33257037 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy
Number of subjects: 100
Study 33257037 — intervention group
Group type: COMPARATOR
Intervention: Standard sterile dressing
Number of subjects: 100
Study 33864390 — intervention group
Group type: EXPERIMENTAL
Intervention: Marital First Responders‐AA, a culturally adapted version of the Marital First Responders program
Number of subjects: 0
Study 33188136 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (TOFA)
Number of subjects: 85
Study 33188136 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (BARI)
Number of subjects: 85
Study 33188136 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib (UPA)
Number of subjects: 85
Study 33188136 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib (FILGO)
Number of subjects: 85
Study 33188136 — intervention group
Group type: EXPERIMENTAL
Intervention: Decernotinib (DEC)
Number of subjects: 85
Study 33188136 — intervention group
Group type: EXPERIMENTAL
Intervention: Peficitinib (PEF)
Number of subjects: 85
Study 33188136 — intervention group
Group type: COMPARATOR
Intervention: JAK inhibitors (JAKi)
Number of subjects: 85
Study 33188136 — intervention group
Group type: COMPARATOR
Intervention: Control (TNFi)
Number of subjects: 85
Study 34429511 — intervention group
Group type: EXPERIMENTAL
Intervention: LION procedure
Number of subjects: 17
Study 34429511 — intervention group
Group type: COMPARATOR
Intervention: NMES
Number of subjects: 17
Study 34269398 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific vasoactive therapy
Number of subjects: 1
Study 34269398 — intervention group
Group type: COMPARATOR
Intervention: Underlying heart and lung disease treatment
Number of subjects: 1
Study 32666060 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular mode polymerization (600‐650 mW/cm2 for 20 s)
Number of subjects: 50
Study 32666060 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power mode polymerization (1200‐1300 mW/cm2 for 10 s)
Number of subjects: 50
Study 32666060 — intervention group
Group type: COMPARATOR
Intervention: Both polymerization modes (Regular and High-power)
Number of subjects: 50
Study 35344441 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural Justice (PJ) training
Number of subjects: 0
Study 33373541 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver Diamine Fluoride (SDF)
Number of subjects: 40
Study 33373541 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 Laser
Number of subjects: 40
Study 33373541 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 Laser followed by SDF
Number of subjects: 40
Study 33373541 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 40
Study 32709516 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) and Postural Correction Exercises (PCE)
Number of subjects: 91
Study 32709516 — intervention group
Group type: COMPARATOR
Intervention: Postural Correction Exercises (PCE)
Number of subjects: 91
Study 32709516 — intervention group
Group type: COMPARATOR
Intervention: Kinesio Taping (KT)
Number of subjects: 91
Study 35719836 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycii Fructus extract (LFE) 900 mg/day
Number of subjects: 0
Study 35719836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32899031 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator thrombolytic therapy
Number of subjects: 0
Study 32899031 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33996266 — intervention group
Group type: EXPERIMENTAL
Intervention: High intratumoral CXCL13+CD8+ T cells infiltration
Number of subjects: 440
Study 33996266 — intervention group
Group type: EXPERIMENTAL
Intervention: CXCL13+CD8+ T cells
Number of subjects: 440
Study 33996266 — intervention group
Group type: EXPERIMENTAL
Intervention: Combinational analysis of CXCL13+CD8+ T cells and CD8+ T cells infiltration
Number of subjects: 440
Study 33996266 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral CXCL13+CD8+ T cells infiltration
Number of subjects: 440
Study 34677668 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 205
Study 34677668 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature
Number of subjects: 205
Study 33354769 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily smartphone-based monitoring including a feedback loop
Number of subjects: 98
Study 33354769 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 98
Study 32928255 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (PN)
Number of subjects: 1128
Study 32928255 — intervention group
Group type: COMPARATOR
Intervention: Late parenteral nutrition (PN)
Number of subjects: 1128
Study 32928255 — intervention group
Group type: EXPERIMENTAL
Intervention: Upon-admission GDF15
Number of subjects: 1128
Study 32928255 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower GDF15
Number of subjects: 1128
Study 35332521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided proximal suprascapular nerve block with 5 ml ropivacaine 7.5 mg/ml
Number of subjects: 0
Study 35332521 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 ml isotonic NaCl)
Number of subjects: 0
Study 33106167 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care and 200 ml convalescent plasma (CP)
Number of subjects: 60
Study 33106167 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care and 400 ml convalescent plasma (CP)
Number of subjects: 60
Study 33106167 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 33106167 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care and 200 ml CP
Number of subjects: 60
Study 33106167 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care and 400 ml CP
Number of subjects: 60
Study 36173384 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk powder
Number of subjects: 122
Study 36173384 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole egg powder
Number of subjects: 122
Study 36173384 — intervention group
Group type: COMPARATOR
Intervention: Gelatin (placebo)
Number of subjects: 122
Study 34236768 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate dose enoxaparin
Number of subjects: 176
Study 34236768 — intervention group
Group type: COMPARATOR
Intervention: Standard prophylactic dose enoxaparin
Number of subjects: 176
Study 32369460 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol solution
Number of subjects: 140
Study 32369460 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 140
Study 35669372 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group (image recognition algorithm for feature extraction, segmentation, and classification)
Number of subjects: 268
Study 35669372 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard classification method)
Number of subjects: 268
Study 34023746 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication (specific type not mentioned)
Number of subjects: 665
Study 34023746 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 665
Study 35483181 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal consequences
Number of subjects: 349
Study 35483181 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapersonal consequences (e.g., sad mood)
Number of subjects: 349
Study 35483181 — intervention group
Group type: EXPERIMENTAL
Intervention: Social responsibility consequences (particularly financial)
Number of subjects: 349
Study 35483181 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption measures
Number of subjects: 349
Study 33368991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography guided penile nerve block (PNB)
Number of subjects: 80
Study 33368991 — intervention group
Group type: COMPARATOR
Intervention: Control (no PNB)
Number of subjects: 80
Study 33516790 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 3 rENE
Number of subjects: 1887
Study 33516790 — intervention group
Group type: COMPARATOR
Intervention: Proposed N category system
Number of subjects: 1887
Study 34126426 — intervention group
Group type: EXPERIMENTAL
Intervention: Predisposition condition (indicating heightened schizophrenia risk)
Number of subjects: 1601
Study 34126426 — intervention group
Group type: EXPERIMENTAL
Intervention: No-predisposition condition (indicating no heightened schizophrenia risk)
Number of subjects: 1601
Study 34126426 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no mention of genetic testing)
Number of subjects: 1601
Study 34126426 — intervention group
Group type: EXPERIMENTAL
Intervention: Predisposition condition (in Experiment 2)
Number of subjects: 1601
Study 34126426 — intervention group
Group type: EXPERIMENTAL
Intervention: No-predisposition condition (in Experiment 2)
Number of subjects: 1601
Study 36137627 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine during ROP eye examinations
Number of subjects: 0
Study 33978132 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based (HB) aerobic training combined with food orientation
Number of subjects: 23
Study 33978132 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised (face‐to‐face, FF) aerobic training combined with food orientation
Number of subjects: 23
Study 33978132 — intervention group
Group type: COMPARATOR
Intervention: Both HB and FF groups
Number of subjects: 23
Study 32169523 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 262
Study 32169523 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral skills training
Number of subjects: 262
Study 32169523 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 262
Study 34302120 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR) for 8 weeks, followed by food-reintroduction over 4 weeks, with weekly behavioral support for 8 weeks, bi-weekly for 4 weeks, then monthly for 3 months
Number of subjects: 179
Study 34302120 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR)
Number of subjects: 179
Study 34302120 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 179
Study 32784257 — intervention group
Group type: EXPERIMENTAL
Intervention: RED PBM
Number of subjects: 174
Study 32784257 — intervention group
Group type: EXPERIMENTAL
Intervention: INFRARED PBM
Number of subjects: 174
Study 32784257 — intervention group
Group type: COMPARATOR
Intervention: PLACEBO (Sham) treatment
Number of subjects: 174
Study 34475171 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaxcards incentive
Number of subjects: 3087
Study 34475171 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Vaxcards)
Number of subjects: 3087
Study 34475171 — intervention group
Group type: EXPERIMENTAL
Intervention: Historical return rates
Number of subjects: 3087
Study 32357314 — intervention group
Group type: EXPERIMENTAL
Intervention: FAAM‐D (digital version)
Number of subjects: 90
Study 32357314 — intervention group
Group type: COMPARATOR
Intervention: FAAM‐P (paper version)
Number of subjects: 90
Study 36279266 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy (LLLT), administered three times a week for 3 weeks
Number of subjects: 47
Study 36279266 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal Shock Wave Therapy (ESWT), administered once a week for 3 weeks
Number of subjects: 47
Study 32698618 — intervention group
Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 60
Study 32698618 — intervention group
Group type: EXPERIMENTAL
Intervention: F-SMILE
Number of subjects: 60
Study 32698618 — intervention group
Group type: COMPARATOR
Intervention: Comparison between LASIK and F-SMILE
Number of subjects: 60
Study 35966074 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOICE diet (60% complex carbohydrate/25% fat/15% protein)
Number of subjects: 34
Study 35966074 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOICE diet
Number of subjects: 34
Study 35966074 — intervention group
Group type: COMPARATOR
Intervention: CONV diet (40% complex carbohydrate/45% fat/15% protein)
Number of subjects: 34
Study 32016653 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation (MV)
Number of subjects: 147
Study 32016653 — intervention group
Group type: COMPARATOR
Intervention: No multivitamin supplementation (MV)
Number of subjects: 147
Study 32016653 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without MV)
Number of subjects: 147
Study 36177637 — intervention group
Group type: EXPERIMENTAL
Intervention: ReMotion TWA
Number of subjects: 40
Study 36177637 — intervention group
Group type: EXPERIMENTAL
Intervention: Motec TWA
Number of subjects: 40
Study 36177637 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 34332453 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice using a feedback device (FD) during CPR training
Number of subjects: 60
Study 32078161 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct visual targeting of the anterior thalamic nucleus (ANT)
Number of subjects: 12
Study 32078161 — intervention group
Group type: COMPARATOR
Intervention: Preset coordinates for ANT electrode implantation
Number of subjects: 12
Study 616731945 — intervention group
Group type: EXPERIMENTAL
Intervention: Motorized vehicle-mounted sprayer (VMS)
Number of subjects: 76
Study 616731945 — intervention group
Group type: COMPARATOR
Intervention: Manual compression sprayers (MCS)
Number of subjects: 76
Study 35708481 — intervention group
Group type: EXPERIMENTAL
Intervention: Mézières Method (MM)
Number of subjects: 139
Study 35708481 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation protocol
Number of subjects: 139
Study 34789188 — intervention group
Group type: EXPERIMENTAL
Intervention: Training at a fitness center
Number of subjects: 3764
Study 34789188 — intervention group
Group type: COMPARATOR
Intervention: No access to training (no-training arm)
Number of subjects: 3764
Study 33249985 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream with lipid nanoparticles and vitamin E (Group A)
Number of subjects: 108
Study 33249985 — intervention group
Group type: COMPARATOR
Intervention: Cream without nanoparticles nor vitamin E (Group B)
Number of subjects: 108
Study 33249985 — intervention group
Group type: COMPARATOR
Intervention: Cream with nanoparticles without vitamin E (Group C)
Number of subjects: 108
Study 33249985 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 108
Study 35688438 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain of 0 to 4.9 kg
Number of subjects: 16808
Study 35688438 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss during pregnancy
Number of subjects: 16808
Study 35688438 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain above recommendations (≥ 9.1 kg)
Number of subjects: 16808
Study 35688438 — intervention group
Group type: COMPARATOR
Intervention: Weight gain within recommendations (5-9.09 kg)
Number of subjects: 16808
Study 35904836 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 36
Study 35904836 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated growth factors (CGF)
Number of subjects: 36
Study 35904836 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 33069668 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 60
Study 33069668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 99050181 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary alternative ($5.00 voucher)
Number of subjects: 7
Study 99050181 — intervention group
Group type: EXPERIMENTAL
Intervention: Active marijuana (1.8% or 3.9% THC)
Number of subjects: 7
Study 99050181 — intervention group
Group type: COMPARATOR
Intervention: Placebo marijuana (0.0% THC)
Number of subjects: 7
Study 99050181 — intervention group
Group type: EXPERIMENTAL
Intervention: Task performance criteria (80, 100, or 120% of baseline)
Number of subjects: 7
Study 99050181 — intervention group
Group type: EXPERIMENTAL
Intervention: THC concentration
Number of subjects: 7
Study 32993355 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 2 (SFSe) with 12.605 mg/kg Se additive
Number of subjects: 240
Study 32993355 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 4 (USFSe) with 12.605 mg/kg Se additive
Number of subjects: 240
Study 32993355 — intervention group
Group type: COMPARATOR
Intervention: Control diet 1 (SFC) with no added Se
Number of subjects: 240
Study 32993355 — intervention group
Group type: COMPARATOR
Intervention: Control diet 3 (USFC) with no added Se
Number of subjects: 240
Study 32993355 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard temperature (20°C)
Number of subjects: 240
Study 32993355 — intervention group
Group type: EXPERIMENTAL
Intervention: High temperature (35°C)
Number of subjects: 240
Study 32993355 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium addition in both diets
Number of subjects: 240
Study 32026826 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (HA+HS with oscillatory‐PEP)
Number of subjects: 22
Study 32026826 — intervention group
Group type: COMPARATOR
Intervention: Usual care (HA+HS followed by autogenic drainage)
Number of subjects: 22
Study 34543687 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP treatment (systolic BP <120 mm Hg)
Number of subjects: 716